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Abstract 
Introduction: Patients presenting with acute ST-
elevation myocardial infarction (STEMI) of less than 12 
hours from onset of chest pain are candidates for 
primary percutaneous coronary intervention (PPCI).  
Aim:  To assess the patients’ outcome after 12 
months of their admission by a retrospective 
observational study.  
Methodology: Data of patients admitted with 
STEMI and preceding to PPCI between 1st of January 
2011 to 30th of June 2011 were analyzed. A total of 105 
patients were recruited, identified and analyzed by using 
Cardiac Investigation and Patient Record (CIPR) 
software. Survival outcomes were determined by 
mortality data obtained from the Department of 
Information, Health and Research.  
Results: Out of the 105 patients having PPCI, the 
majority were men (81%). 8.6% died within one year. 
20% had scheduled repeat coronary angiography, 9.5% 
requiring further PCI. 0.95% had target vessel 
revascularization while another 0.95% was referred for 
coronary artery bypass grafting (CABG) due to triple 
vessel coronary disease.  
Unplanned re-admissions rate due to another 
episode of chest pain was of 5.7%, out of which one 
presented with another STEMI requiring PPCI. The 
other patients underwent inpatient coronary angiogram, 
with 2 proceeding to PCI.  
The remaining 63% did not experience any other 
cardiovascular related episodes. 
 
Conclusion: This analysis showed that the re-
admission rates over a year requiring further 
interventions were low as was the death rate. Only one 
target vessel revascularization was performed suggesting 
that the majority of the PPCI’s performed were 
successful. This is important when assessing the quality 
of cardiovascular interventional service provided by our 
state health system.  
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Introduction 
Acute ST-segment elevation myocardial infarction 
(STEMI) is an emergency condition, which results from 
a thrombotic occlusion of a coronary artery. Impairment 
of vascular supply to the myocardium occurs, leading to 
an eventual infarction.1  
Primary percutaneous coronary intervention (PPCI) 
is the gold standard for STEMI management2 provided 
that a PPCI center is within a reasonable geographical 
distance to ensure a rapid revascularization as possible. 
The other alternative to treat acute STEMI is 
thrombolysis. The earlier the patient presents to the 
Emergency department after onset of chest pain, the 
better results would be obtained by PPCI. When 
comparing PPCI to thrombolysis, it had been found that 
PCI is superior to thrombolysis when undertaken 
between 3 and 12 hours from the onset of chest pain, as 
it significantly leads to a more rapid and effective 
revascularization. It had been reported that in particular 
women3 and elderly patients4 benefit more from 
undergoing PPCI as compared to thrombolysis.  
The PPCI procedure involves acquiring arterial 
access (originally through the femoral artery but 
nowadays the use of the radial or brachial arteries are 
also possible) under local anaesthesia, where a seldinger 
technique is used to guide a catheter up to the coronary 
artery. Visualization by means of intracoronary contrast 
medium injections and fluoroscopy would enable the 
catheter to be passed through the stenosis and into its 
distal branch5. The stenosis would then be dilated and 
stented, resulting in the return of blood flow through the 
vessel to the distal myocardium. The outcome depends 
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on the presence of co-morbid factors such as pre-
existing heart failure or renal failure, previous 
myocardial infarction, the degree of vessel 
collateralisation and the presence of multi-vessel 
disease5. These in addition to the duration of the door-to-
balloon time, a prognostic factor in its own right.  
This study was undertaken at Mater Dei Hospital, 
which is equipped with a PPCI facility and experienced 
team. Due to the relatively small size of the islands, 
patients experiencing acute chest pain have a greater 
chance of reaching the hospital within the first few hours 
of the onset and so the door-to-balloon time is generally 
short. The local protocol is that patients presenting to the 
Accident and Emergency department of Mater Dei 
Hospital with acute STEMI up to 12 hours duration are 
candidates for PPCI. Circulatory system diseases 
including ischemic heart disease6 constitute the major 
cause of death in Malta over recent years (38% of the 
death rate for 2010). This retrospective observational 
study was performed to assess the outcome of patients’ 
cardiovascular interventional outcome at 12 months of 
having undergone PPCI.  
 
Method 
Over a 6 month period between the 1st of January 
2011 to 30th June 2011, a total of 105 patients presented 
to the Accident and Emergency department of Mater Dei 
Hospital, Malta, with acute onset of chest pain, where an 
electrocardiogram in each case showed acute STEMI. 
These subjects were candidates to undergo PPCI.  
Permission for PPCI data covering this period was 
obtained from the cardiologist consultants, the Mater 
Dei hospital administration and the data protection 
office.  The researchers kept no personal data of the 
subjects in this study.  
A total of 105 patients were identified and analyzed 
by using the Cardiac Investigation and Patient Record 
(CIPR) software available at the time of presentation and 
during data collection. The CIPR software was Maltese 
designed software used at Mater Dei Hospital to log in 
and save all data from angiograms and angioplasties 
performed7, along with any other re-admissions 
requiring further interventions for each patient. Using 
this software, each patient under study was individually 
screened to assess for any additional interventions in the 
following 12 months. Nowadays, this software has been 
superseded by international software.  
Special attention was given to those patients that 
were admitted again for additional target vessel 
revascularization after their STEMI admission. Survival 
outcomes of these patients were determined using 
mortality data obtained from the Department of 
Information, Health and Research, Ministry of Health, 
the Elderly and Community Care, Malta.  
 
 
Results 
Of the 105 patients having undergone PPCI in the 
studied period, 81% of the patients were men (n= 85).  
The death rate in this cohort after a year was 8.6% 
(n=9), with 4.8% being men (n=5) and 3.8% female 
(n=4), with their age varying between 67 years and 95 
years. Graph 1 shows the time of death after PPCI.  
 
Graph 1: Time of death after PPCI 
 
 
 
 
 
 
 
 
 
 
 
 
 
20% of the patients (n=21) had a scheduled repeat 
coronary angiogram 1 to 3 months after the PPCI. 9.5% 
(n=10) did not require any further intervention, while 
one -0.95% was found to have triple coronary artery 
disease and was referred to the cardiothoracic surgeons 
for coronary artery bypass grafting (CABG). Of the 
remaining 9.5% (n=10), one - 0.95% needed target 
vessel revascularization (i.e. PCI to the same vessel that 
had the initial PPCI) while the other 8.6% (n=9) had had 
PCI to other coronary vessels. One of these patients died 
3 months following the scheduled PCI. 
There was a re-admission rate of 5.7% (n=6) who 
presented to the Accident and Emergency department 
again with another episode of chest pain, out of which 
0.95% (one) presented with another acute STEMI 
requiring PPCI due to an in-stent thrombosis. The other 
4.75% (n=5) patients underwent an inpatient coronary 
angiogram, with 2 proceeding to PCI. 0.95% (n=1) out 
of the patients undergoing inpatient coronary angiogram 
had previously undergone scheduled repeated coronary 
angiography, which had taken place 15 days prior to the 
re-admission with chest pain.  
The majority of the patients - 63% (n=66) did not 
experience any cardiovascular related episodes requiring 
interventions within one year of having had PPCI.  
  
Discussion 
In certain STEMI cases such as those with onset of 
chest pain exceeding 12 hours, thrombolysis is usually 
undertaken at Mater Dei hospital.  
The majority of the subjects presenting with STEMI 
were men. This may be due to the fact that men are more 
at risk to develop cardiovascular disease throughout the 
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world especially when compared to premenopausal 
women.  
In a recent meta-analysis, a significant death 
reduction was found in patients having undergone PCI 
as compared to thrombolysis though no significant 
reduction was found in cardiac deaths and myocardial 
infarction8. In the DANAMI-2 trial it was shown that a 
significant reduction in the primary endpoint of death, 
re-infarction and stroke after 30 days with PPCI was 
evident9.  
Nowadays, as per latest guidelines, patients need to 
be on dual antiplatelet therapy (Aspirin and Clopidogrel) 
for a period of 1 year after a myocardial infarction in 
Malta. In 2010, the practice was slightly different, where 
patients were discharged on aspirin and ticlopdine.  
Ticlopidine is not as effective as an antiplatelet agent as 
clopidogrel, where at the time it was not yet available on 
the NHS drug formula.  
Scheduled angiograms after PPCI are usually 
booked for patients having extensive coronary disease 
either to the culprit vessel or to other coronary vessels. 
The re-admission rate after the initial PPCI was low 
due to cardiovascular-related conditions requiring 
further intervention. There was only one re-admission 
related to stent restenosis and required target-vessel re-
vascularization.  Stent thrombosis is a relatively rare 
complication.10 
Two studies were found on re-admissions after 
PPCI, stating that re-admissions due to associated 
cardiovascular complications are more likely to occur 
within 30 days of the PCI.11-12 When implementing this 
to our study, only 1 subject was re-admitted with chest 
pain within the 30-day window post-PPCI. The 
remainder 5 patients were re-admitted beyond the 30-
days of PPCI. The 30-day re-admission rate in some 
countries has now become a “quality indicator” for 
congestive heart failure as well as to acute myocardial 
infarction and being used as a means to assess health 
systems.13  
Possible closer follow-up after PPCI might have 
identified some of these cardiovascular problems at an 
earlier stage and prevented the re-admission.14 Assessing 
compliance to medications might prevent re-infarction, 
bleeding and stent thrombosis.15  
The majority of the subjects that had undergone a 
PPCI in this study did not present to hospital in need of 
further cardiovascular associated invasive procedures 
within the one-year follow-up. This could be interpreted, 
as suggesting that the majority of the PPCI’s performed 
was successful.  
 
Study limitations 
None of the patients were actually contacted nor 
was their medical file reviewed; therefore one cannot 
say whether their deaths were directly linked to 
cardiovascular consequences. Also, this does not allow 
for further discussion on the effects of other therapies 
and co-morbidity. Any data missing from the software 
used would also have been left out from this study. Due 
to lack of electronic medical records for outpatient visits, 
any patients presenting to the cardiac medical 
outpatients within the follow-up period was not included 
in this study. Only patients having undergone invasive 
procedures at the hospital were taken into consideration. 
All subjects presenting to private hospitals were 
excluded.   
The study lacked information on the medical 
history and presence of any co-morbidity that may have 
been present for each patient and which may have led to 
their differing prognosis.  
Conclusion 
This study documented that re-admission rates over 
a 1-year follow-up period requiring further interventions 
were low. The majority of the re-admissions were for 
scheduled angiograms. The possible strategy for the 
other unplanned re-admissions would be shorter duration 
to follow-ups at the medical outpatients to prevent 
development of complications as well as monitor 
treatment compliance. Interestingly to notice is that the 
majority of the studied cohort needed no further 
cardiovascular interventions over 1-year. Additionally 
the death rate was relatively low. This information is 
important when assessing the quality cardiovascular 
interventional service provided by our state health 
system.  
 
Reference 
1. NICE. Myocardial infarction with ST-segment-elevation 
(STEMI). National Institute for Health and Clinical Excellence, 
2013.  
2. Rathod KS, Jones DA, Gallagher SM, et al. BMJ Open 2013; 
3:e003063. 
3. Tamis-Holland JE, Palazzo A, Stebbins AL, et al. Benefits of 
direct angioplasty for women and men with acute myocardial 
infarction: results of the Global Use of Strategies to Open 
Occluded Arteries in Acute Coronary Syndrome Angiopalsty 
(GUSTO II-B) Angioplasty Substudy. Am Heart J. 2004; 147: 
133-139. 
4. Goldenberg I, Matetzky S, Halkin A, Roth A, et al. Primary 
angioplasty with routine stenting compared with thrombolytic 
therapy in elderly patients with acute myocardial infarction. 
AM Heart J 2003; 145: 862 – 867.   
5. Grech ED. ABC of interventional cardiology. Percutaneous 
coronary intervention. II: The procdure. BMJ 2003; 326: 1137 
– 1140. 
6. European Health Examination Survey 2010 – Pilot Study, 
Department of Health Information and Research, Ministry of 
Health, the Elderly and Community Care.  
7. Cardiac Investigation & Patient Records (CIPR). [Accessed on 
08/12/13] Available at: 
http://www.stockholmchallenge.org/project/data/cardiac-
investigation-patient-records-cipr. 
8. Keely EC, Boura JA, Grines CL. Primary angioplasty versus 
intravenous thrombolytic therapy for acute myocardial 
infarction: a quantitative review of 23 randomized trials. 
Lancet. 2003; 361: 13 - 20. 
19
  
 
 
 
Original Article   
 
 
Malta Medical Journal    Volume 26 Issue 04 2014  
 
 
9. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison 
of coronary angioplasty with fibrinolytic therapy in acute 
myocardial infarction. N. Engl J Med 2003; 349: 733 – 742. 
10. Stone GW, Rizvi A, Newman W, et al. for the SPIRIT IV 
Investigators. Everolimus-eluting versus paclitaxel-eluting 
stents in coronary artery disease. N Engl J Med 2010; 362: 
1663-74.  
11. Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission 
and repeat revascularization after percutaneous coronary 
intervention in a cohort of Medicare patients. J Am Coll 
Cardiol 2009; 54: 903-907. 
12. Hannan E, Zhong Y, Krumholz H, et al. 30-Day Readmission 
for Patients undergoing Percutaneous Coronary Interventions in 
New York State. Jacc: Cardiovascular Interventions 2011; 4: 
1335 – 1342 
13. Yost GW, Puher SL, Graham J, et al. Readmission in the 20 
days after percutaneous coronary intervention. JACC: 
Cardiovascular interventions 2013; 6(3): 237-44. 
14. Hernandez AF, Greiner MA, Fonarow, et al. Relationship 
between early physician follow-up and 30-day readmission 
among Medicare beneficiaries hospitalized for heart failure. 
JAMA 2010; 303: 1716-22 
15. Levine GN, Bates ER, Blankenship JC, et al. 2011 
ACCF/AHA/SCAI guideline for percutaneous coronary 
intervention: a report of the American College of Cardiology 
Foundation / American Heart Association Task Force on 
Practice Guidelines and the Society for Cardiovascular 
Angiography and Interventions. J Am Coll Cardiol 2011; 58: 
e44-122. 
 
 
 
 
 
 
 
 
 
 
 
 
 
20
